Trial Profile
A Phase I and Pharmacologic Study of UCN-01 (NSC638850)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 May 2018
Price :
$35
*
At a glance
- Drugs UCN 01 (Primary)
- Indications B-cell prolymphocytic leukaemia; Cancer; Chronic lymphocytic leukaemia; Follicular lymphoma; Hairy cell leukaemia; Lymphoproliferative disorders; Mantle-cell lymphoma; Marginal zone B-cell lymphoma; Non-Hodgkin's lymphoma; T-cell prolymphocytic leukaemia; Waldenstrom's macroglobulinaemia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 21 May 2018 New trial record